A state-of-the-art cancer centre is scheduled to open within Holmesglen Private Hospital in September this year, offering the latest in advanced radiation therapy.
Genomics is the focus for the first day of the annual health data conference of the Australasian Institute of Digital Health (AIDH), HealthData21.
UNSW's Kirby Institute has used mathematical modelling to test the effectiveness of different vaccination strategies for controlling the COVID-19 pandemic.
Victorian women who have undergone breast implant or breast reconstructive procedures are being encouraged to watch for early symptoms of a rare form of cancer.
Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.
One million sterilisation wraps will be produced each month in response to a critical worldwide shortage that threatens surgery cancellations in Australia.
Treating high-risk patients with recommended blood pressure and cholesterol-lowering medicines could prevent more than 103,000 heart attacks, strokes and heart-related deaths.
The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.
In the washroom, Australians are most concerned about their co-workers not washing their hands, touching door handles and taps, and the cleanliness of the air.
Researchers at the Cochrane Collaboration reviewed 33 studies involving nearly 5000 participants, relating to antidepressant discontinuation.
A Singapore–Australia travel bubble may be possible with fast and accurate ways to test and clear incoming visitors.
HeraMED has signed an agreement with Joondalup Health Campus in Western Australia to incorporate a paid pilot of the HeraCARE solution.
Patients with low back pain have been shown to respond well to NSAIDs such as ibuprofen, according to researchers at RMIT University.
Johnson & Johnson Innovation has facilitated a collaboration between WEHI and Janssen Pharmaceutica NV to ignite the development of antimalarial drug candidates.
SHPA will continue to advocate for investment in embedding geriatric medicine pharmacists as part of clinical pharmacy services for aged-care residents.